secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARLSMED, INC. (CARL)
CIK:        0001794546
Form:       8-K
Filed at:   2026-08-05T20:05:16+00:00
Accession:  0001794546-26-000015
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Carlsmed Q2 revenue $18.9M (+57% YoY); raises FY2026 guidance to $74-78M
------------------------------------------------------------------------

- Revenue $18.9M, up 57% YoY from $12.1M; gross margin 76.8% vs 73.4%.
- Net loss ($10.5M) vs ($6.8M) prior year; adjusted EBITDA ($8.6M).
- Full-year 2026 revenue guidance raised to $74-78M (prior $72-77M), >50% growth at midpoint.
- Trained surgeon users up >60% YoY; aprevo cervical now ~10% of quarterly revenue.
- CMS IPPS final rule includes new MS-DRG codes for inpatient aprevo lumbar, effective Oct 1, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1794546/000179454626000015/0001794546-26-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1794546/000179454626000015/carl-20260805.htm
  HTML page:      https://secwatch.observer/filing/0001794546-26-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer